Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Spicer

Showing results (51-60 of 76) with videos related to

Pageof 8
Sort By:
Cancer Immunology, Immunotherapy : CII|December 6, 2011
Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical applicationSophia N Karagiannis, Debra H Josephs, Panagiotis Karagiannis, et al.
Ebiomedicine|April 9, 2019
IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural statesGiulia Pellizzari, Coran Hoskin, Silvia Crescioli, et al.
Oncoimmunology|December 7, 2017
CAR T-cell immunotherapy of MET-expressing malignant mesotheliomaThivyan Thayaparan, Roseanna M Petrovic, Daniela Y Achkova, et al.
Allergy|April 10, 2019
AllergoOncology: Expression platform development and functional profiling of an anti-HER2 IgE antibodyKristina M Ilieva, Judit Fazekas-Singer, Heather J Bax, et al.
Oncotarget|November 5, 2017
BRAF inhibitors: resistance and the promise of combination treatments for melanomaMerope Griffin, Daniele Scotto, Debra H Josephs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2018
Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of CancerTamara Muliaditan, James W Opzoomer, Jonathan Caron, et al.
Oncoimmunology|May 10, 2019
Immune mediator expression signatures are associated with improved outcome in ovarian carcinomaMano Nakamura, Heather J Bax, Daniele Scotto, et al.
Scientific Reports|June 3, 2020
Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)Ricarda M Hoffmann, Silvia Mele, Anthony Cheung, et al.
Cancers|November 18, 2020
IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory PhenotypeMano Nakamura, Elmira Amiri Souri, Gabriel Osborn, et al.
Oncoimmunology|October 10, 2015
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanomaPanagiotis Karagiannis, Federica Villanova, Debra H Josephs, et al.
Pageof 8

Showing results (51-60 of 76) with videos related to

Sort By:
Pageof 8
Cancer Immunology, Immunotherapy : CII|December 6, 2011
Recombinant IgE antibodies for passive immunotherapy of solid tumours: from concept towards clinical applicationSophia N Karagiannis, Debra H Josephs, Panagiotis Karagiannis, et al.
Ebiomedicine|April 9, 2019
IgE re-programs alternatively-activated human macrophages towards pro-inflammatory anti-tumoural statesGiulia Pellizzari, Coran Hoskin, Silvia Crescioli, et al.
Oncoimmunology|December 7, 2017
CAR T-cell immunotherapy of MET-expressing malignant mesotheliomaThivyan Thayaparan, Roseanna M Petrovic, Daniela Y Achkova, et al.
Allergy|April 10, 2019
AllergoOncology: Expression platform development and functional profiling of an anti-HER2 IgE antibodyKristina M Ilieva, Judit Fazekas-Singer, Heather J Bax, et al.
Oncotarget|November 5, 2017
BRAF inhibitors: resistance and the promise of combination treatments for melanomaMerope Griffin, Daniele Scotto, Debra H Josephs, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 18, 2018
Repurposing Tin Mesoporphyrin as an Immune Checkpoint Inhibitor Shows Therapeutic Efficacy in Preclinical Models of CancerTamara Muliaditan, James W Opzoomer, Jonathan Caron, et al.
Oncoimmunology|May 10, 2019
Immune mediator expression signatures are associated with improved outcome in ovarian carcinomaMano Nakamura, Heather J Bax, Daniele Scotto, et al.
Scientific Reports|June 3, 2020
Rapid conjugation of antibodies to toxins to select candidates for the development of anticancer Antibody-Drug Conjugates (ADCs)Ricarda M Hoffmann, Silvia Mele, Anthony Cheung, et al.
Cancers|November 18, 2020
IgE Activates Monocytes from Cancer Patients to Acquire a Pro-Inflammatory PhenotypeMano Nakamura, Elmira Amiri Souri, Gabriel Osborn, et al.
Oncoimmunology|October 10, 2015
Elevated IgG4 in patient circulation is associated with the risk of disease progression in melanomaPanagiotis Karagiannis, Federica Villanova, Debra H Josephs, et al.
Pageof 8